BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10954662)

  • 1. Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients.
    Shaw JC
    J Am Acad Dermatol; 2000 Sep; 43(3):498-502. PubMed ID: 10954662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects and side-effects of spironolactone therapy in women with acne.
    Yemisci A; Gorgulu A; Piskin S
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):163-6. PubMed ID: 15752283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone.
    Krunic A; Ciurea A; Scheman A
    J Am Acad Dermatol; 2008 Jan; 58(1):60-2. PubMed ID: 17964689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experience in the therapy of acne with topical administration of spironolactone as an antiandrogen].
    Califano L; Cannavò S; Siragusa M; Girardi R
    Clin Ter; 1990 Nov; 135(3):193-9. PubMed ID: 2150020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose schema of isotretinoin in acne vulgaris.
    Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
    Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spironolactone and topical retinoids in adult female cyclical acne.
    Lessner E; Fisher S; Kobraei K; Osleber M; Lessner R; Elliott L; Wesson S
    J Drugs Dermatol; 2014 Feb; 13(2):126-9. PubMed ID: 24509960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral isotretinoin for acne, adjusting treatment according to patient's response.
    Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
    J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal therapy for acne.
    George R; Clarke S; Thiboutot D
    Semin Cutan Med Surg; 2008 Sep; 27(3):188-96. PubMed ID: 18786497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recurrence in patients diagnosed with acne treated by isotretinoin and other methods].
    Bergler-Czop B; Brzezińska-Wcisło L
    Wiad Lek; 2006; 59(3-4):152-7. PubMed ID: 16813256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of pyruvic acid in the treatment of acne.
    Cotellessa C; Manunta T; Ghersetich I; Brazzini B; Peris K
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):275-8. PubMed ID: 15096135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose isotretinoin in the treatment of acne vulgaris.
    Amichai B; Shemer A; Grunwald MH
    J Am Acad Dermatol; 2006 Apr; 54(4):644-6. PubMed ID: 16546586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
    Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Spironolactone administered topically in the treatment of acne].
    Tomidei M; Strani G
    Clin Ter; 1987 Jul; 122(2):99-105. PubMed ID: 2973907
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment.
    Leyden JJ; Shalita A; Thiboutot D; Washenik K; Webster G
    Clin Ther; 2005 Feb; 27(2):216-24. PubMed ID: 15811485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Side effects of treatment with isotretinoin in patients with acne].
    Bergler-Czop B; Brzezińska-Wcisło L
    Pol Merkur Lekarski; 2005 Jun; 18(108):680-5. PubMed ID: 16124383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term low-dose spironolactone therapy is safe in oligoanuric hemodialysis patients.
    Matsumoto Y; Kageyama S; Yakushigawa T; Arihara K; Sugiyama T; Mori Y; Sugiyama H; Ohmura H; Shio N
    Cardiology; 2009; 114(1):32-8. PubMed ID: 19342857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral cephalexin for acne vulgaris: clinical experience with 93 patients.
    Fenner JA; Wiss K; Levin NA
    Pediatr Dermatol; 2008; 25(2):179-83. PubMed ID: 18429774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of spironolactone on mortality in patients with severe left ventricular dysfunction after acute myocardial infarction].
    Ruta J; Ptaszyński P; Maciejewski M; Chizyński K; Goch JH
    Przegl Lek; 2006; 63(12):1249-51. PubMed ID: 17642132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral and topical spironolactone therapies in skin androgenization.
    Messina M; Manieri C; Musso MC; Pastorino R
    Panminerva Med; 1990; 32(2):49-55. PubMed ID: 2147469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.